Garen Bohlin

Garen G.
Bohlin was the founder of Bioverativ Therapeutics, Inc., founded in 1999, where the title held was President & Chief Executive Officer from 1999 to 2008.
Current jobs include Chairman at Curadel Surgical Innovations, Inc., Independent Director at Collegium Pharmaceutical, Inc. since 2015, and Independent Director at Karyopharm Therapeutics, Inc. since 2013.
Former jobs include Chairman at SpringLeaf Therapeutics, Inc. from 2011 to 2014; Director at Praecis Pharmaceuticals, Inc. from 2005 to 2007; Director at Acusphere, Inc. from 2005 to 2015; Independent Director at Proteon Therapeutics, Inc.; Independent Director at Tetraphase Pharmaceuticals, Inc. from 2010 to 2020; Director at Targanta Therapeutics Corp.
from 2007 to 2009; Director at PreCision Dermatology, Inc. from 2012 to 2014; Director at Massachusetts Biotechnology Council; Chief Operating Officer at Sirtris Pharmaceuticals, Inc. from 2006 to 2009; Partner at Arthur Andersen LLP from 1971 to 1983; Executive Vice President at Constellation Pharmaceuticals, Inc. from 2010 to 2012; Executive Vice President at Genetics Institute LLC from 1984 to 1998.
Education includes undergraduate degree from the University of Illinois, conferred in 1970.